Cyclodextrins as pharmaccutical solubilizers

被引:1513
|
作者
Brewster, Marcus E.
Loftsson, Thorsteinn
机构
[1] Janssen Pharmaceut, Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium
[2] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
关键词
cyclodextrin; toxicology; regulatory status; solubility; stability constants; phase-solubility; supersaturation; additives;
D O I
10.1016/j.addr.2007.05.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclodextrins are useful functional excipients that have enjoyed widespread attention and use. The basis for this popularity from a pharmaceutical standpoint, is the ability of these materials to interact with poorly water-soluble drugs and drug candidates resulting in an increase in their apparent water solubility. The mechanism for this solubilization is rooted in the ability of cyclodextrin to form non-covalent dynamic inclusion complexes in solution. Other solubilizing attribute may include the ability to form non-inclusion based complexes, the formation of aggregates and related domains and the ability of cyclodextrins to form and stabilize supersaturated drug solutions. The increase in solubility also can increase dissolution rate and thus improve the oral bioavailability of BCS Class II and IV materials. A number of cyclodextrin-based products have reached the market based on their ability to camouflage undesirable physicochemical properties. This review is intended to give a general background to the use of cyclodextrin as solubilizers as well as highlight kinetic and thermodynamic tools and parameters useful in the study of drug solubilization by cyclodextrins. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:645 / 666
页数:22
相关论文
共 50 条
  • [1] Cyclodextrins as Solubilizers: Formation of Complex Aggregates
    Jansook, Phatsawee
    Kurkov, Sergey V.
    Loftsson, Thorsteinn
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (02) : 719 - 729
  • [2] The Solubility-Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone
    Dahan, Arik
    Miller, Jonathan M.
    Hoffman, Amnon
    Amidon, Gregory E.
    Amidon, Gordon L.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (06) : 2739 - 2749
  • [3] PHARMACCUTICAL INDUSTRY AND DOCTOR - WHAT OF FUTURE
    DOWLING, HF
    NEW ENGLAND JOURNAL OF MEDICINE, 1961, 264 (02): : 75 - &
  • [4] Solubilizers in profinite groups
    Lucchini, Andrea
    JOURNAL OF ALGEBRA, 2024, 647 : 619 - 632
  • [5] Pharmaccutical Inhibition of Neddylation as Promising Treatment for Various Cancers
    Yin, Lina
    Xue, Yuanyuan
    Shang, Qiannan
    Zhu, Haichao
    Liu, Meihua
    Liu, Yingxiang
    Hu, Qingzhong
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (12) : 1059 - 1069
  • [6] MACROCYCLIC POLYAMINES AS CALCULI SOLUBILIZERS
    KIMURA, E
    WATANABE, A
    NIHIRA, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1983, 31 (09) : 3264 - 3268
  • [7] Myco-potash solubilizers
    Parida, B. K.
    Vyas, R. V.
    Jhala, Y. K.
    Dasgupta, S.
    CURRENT SCIENCE, 2019, 116 (01): : 116 - 120
  • [8] MACROMOLECULAR SOLUBILIZERS FOR DRUGS AND HORMONES
    PITHA, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 66 - PMSE
  • [9] EFFECT OF SOLUBILIZERS ON STABILITY OF TETRACYCLINE
    NAGGAR, V
    DAABIS, NA
    MOTAWI, MM
    PHARMAZIE, 1974, 29 (02): : 126 - 129
  • [10] INFLUENCE OF CERTAIN SOLUBILIZERS ON BIOAVAILABILITY OF ACETAZOLAMIDE
    ELSAMALIGY, ME
    HAMZA, YE
    ABDELGAWAD, NA
    PHARMAZEUTISCHE INDUSTRIE, 1992, 54 (04): : 378 - 380